Compare FTW.WS & RNAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Presidio Production Company Warrants each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
Current Price
| Metric | FTW.WS | RNAZ |
|---|---|---|
| Founded | N/A | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.6M | 27.9M |
| IPO Year | N/A | 2021 |
| Metric | FTW.WS | RNAZ |
|---|---|---|
| Price | $1.01 | $1.33 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | N/A | ★ 17.7K |
| Earning Date | N/A | 08-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | N/A | $1.30 |
| 52 Week High | N/A | $12.60 |
| Indicator | FTW.WS | RNAZ |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 31.66 |
| Support Level | N/A | N/A |
| Resistance Level | N/A | $1.93 |
| Average True Range (ATR) | 0.00 | 0.15 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 0.00 | 4.03 |
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.